Special Issue "Algal Toxins"

Quicklinks

A special issue of Marine Drugs (ISSN 1660-3397).

Deadline for manuscript submissions: closed (31 August 2011)

Special Issue Editor

Guest Editor
Prof. Dr. John P. Berry
Department of Chemistry and Biochemistry, Florida International University (FIU), 354/332 Marine Science, Biscayne Bay Campus, 3000 NE 151st St., North Miami, FL 33181, USA
Website: http://www.fiu.edu/~berryj/
E-Mail: john.berry@fiu.edu
Phone: +1 305 919 4569
Fax: +1 305 919 4030
Interests: cyanobacteria; toxins; bioactive compounds; zebrafish embryo model; natural products

Special Issue Information

Dear Colleagues,

Marine and freshwater algae are recognized to produce a diverse array of toxic or otherwise bioactive metabolites. These toxic metabolites are globally widespread, and humans and other animals can be exposed to them through both direct routes, including contamination of drinking water and recreational exposure, and indirect routes, including accumulation of these toxins by (and consequent contamination of) various species of fish, shellfish and other animals used as food. Exposure to these toxins has been linked to both acute health effects, including numerous cases of severe illness and mortality, as well as possible long-term health effects, ranging from higher incidence of certain cancers and neurodegenerative disease to prenatal developmental dysfunction. As such algal toxins are emerging as a potentially important human and environmental health concern. Accordingly, a growing number of studies have likewise emerged to address this issue. Areas of investigation particularly include (1) identification and characterization of new toxins; (2) genes and pathways for biosynthesis; (3) bioaccumulation in aquatic food-webs; (4) environmental and ecological factors that contribute to toxin production; (5) methods and technologies for effective detection and monitoring of toxins; (6) epidemiological studies to evaluate the human health impacts of toxins; and (7) strategies and technologies for mitigation of these threats to human health. In addition to their roles as toxins, a number of these bioactive metabolites have also been investigated with respect to possible development as drugs, or otherwise biomedically useful agents, addressing a range of pharmacological targets, as well as other applications with potential commercial importance, including herbicides and pesticides. This special issue will present a relevant sample of current studies investigating these various aspects of algal toxins.

Prof. Dr. John P. Berry
Guest Editor

Keywords

  • cyanobacteria
  • dinoflagellates
  • diatoms
  • harmful algal blooms
  • polyketides
  • non-ribsomal peptides
  • chemical ecology
  • ecotoxicology

Related Special Issue

Published Papers (17 papers)

by , , , , , , , ,  and
Mar. Drugs 2010, 8(3), 460-470; doi:10.3390/md8030460
Received: 21 January 2010; in revised form: 8 February 2010 / Accepted: 20 February 2010 / Published: 5 March 2010
Show/Hide Abstract | Cited by 2 | PDF Full-text (247 KB) | HTML Full-text | XML Full-text

by
Mar. Drugs 2010, 8(3), 542-564; doi:10.3390/md8030542
Received: 9 February 2010; in revised form: 3 March 2010 / Accepted: 8 March 2010 / Published: 9 March 2010
Show/Hide Abstract | Cited by 42 | PDF Full-text (241 KB) | HTML Full-text | XML Full-text

by , , , ,  and
Mar. Drugs 2010, 8(3), 629-657; doi:10.3390/md8030629
Received: 4 January 2010; in revised form: 10 February 2010 / Accepted: 26 February 2010 / Published: 15 March 2010
Show/Hide Abstract | Cited by 13 | PDF Full-text (583 KB) | HTML Full-text | XML Full-text
abstract graphic

by  and II
Mar. Drugs 2010, 8(3), 678-704; doi:10.3390/md8030678
Received: 6 January 2010; in revised form: 9 March 2010 / Accepted: 10 March 2010 / Published: 16 March 2010
Show/Hide Abstract | Cited by 16 | PDF Full-text (309 KB) | HTML Full-text | XML Full-text
abstract graphic

by , , ,  and
Mar. Drugs 2010, 8(4), 1263-1272; doi:10.3390/md8041263
Received: 21 February 2010; in revised form: 16 March 2010 / Accepted: 7 April 2010 / Published: 15 April 2010
Show/Hide Abstract | Cited by 5 | PDF Full-text (309 KB) | HTML Full-text | XML Full-text

by , , ,  and
Mar. Drugs 2010, 8(5), 1650-1680; doi:10.3390/md8051650
Received: 26 March 2010; in revised form: 2 May 2010 / Accepted: 6 May 2010 / Published: 10 May 2010
Show/Hide Abstract | Cited by 81 | PDF Full-text (684 KB) | HTML Full-text | XML Full-text

by , , , ,  and
Mar. Drugs 2010, 8(6), 1803-1816; doi:10.3390/md8061803
Received: 15 April 2010; in revised form: 2 June 2010 / Accepted: 2 June 2010 / Published: 4 June 2010
Show/Hide Abstract | Cited by 7 | PDF Full-text (562 KB) | HTML Full-text | XML Full-text | Supplementary Files
abstract graphic

by  and
Mar. Drugs 2010, 8(6), 1817-1837; doi:10.3390/md8061817
Received: 13 April 2010; in revised form: 19 May 2010 / Accepted: 3 June 2010 / Published: 9 June 2010
Show/Hide Abstract | Cited by 15 | PDF Full-text (293 KB) | HTML Full-text | XML Full-text

by , , , , , , , , , , , , , , ,  and
Mar. Drugs 2011, 9(9), 1625-1648; doi:10.3390/md9091625
Received: 27 July 2011; in revised form: 5 September 2011 / Accepted: 9 September 2011 / Published: 22 September 2011
Show/Hide Abstract | Cited by 13 | PDF Full-text (1207 KB) | HTML Full-text | XML Full-text

by , , , , ,  and
Mar. Drugs 2011, 9(10), 1715-1730; doi:10.3390/md9101715
Received: 26 August 2011; in revised form: 15 September 2011 / Accepted: 26 September 2011 / Published: 29 September 2011
Show/Hide Abstract | Cited by 4 | PDF Full-text (202 KB) | HTML Full-text | XML Full-text

by , , ,  and
Mar. Drugs 2011, 9(10), 2089-2105; doi:10.3390/md9102089
Received: 9 September 2011; in revised form: 29 September 2011 / Accepted: 14 October 2011 / Published: 24 October 2011
Show/Hide Abstract | Cited by 5 | PDF Full-text (292 KB) | HTML Full-text | XML Full-text

by , ,  and
Mar. Drugs 2011, 9(11), 2164-2175; doi:10.3390/md9112164
Received: 7 September 2011; in revised form: 19 October 2011 / Accepted: 20 October 2011 / Published: 31 October 2011
Show/Hide Abstract | Cited by 13 | PDF Full-text (261 KB) | HTML Full-text | XML Full-text

by , , ,  and
Mar. Drugs 2011, 9(12), 2553-2571; doi:10.3390/md9122553
Received: 20 September 2011; in revised form: 15 November 2011 / Accepted: 2 December 2011 / Published: 8 December 2011
Show/Hide Abstract | Cited by 1 | PDF Full-text (232 KB) | HTML Full-text | XML Full-text
abstract graphic

by  and
Mar. Drugs 2011, 9(12), 2729-2772; doi:10.3390/md9122729
Received: 18 October 2011; in revised form: 29 November 2011 / Accepted: 1 December 2011 / Published: 16 December 2011
Show/Hide Abstract | Cited by 32 | PDF Full-text (393 KB) | HTML Full-text | XML Full-text | Supplementary Files

by , , , , , , , , , , , , ,  and
Mar. Drugs 2012, 10(1), 140-162; doi:10.3390/md10010140
Received: 15 November 2011; in revised form: 29 December 2011 / Accepted: 5 January 2012 / Published: 17 January 2012
Show/Hide Abstract | Cited by 13 | PDF Full-text (654 KB) | HTML Full-text | XML Full-text
abstract graphic

by , , ,  and
Mar. Drugs 2012, 10(5), 1044-1065; doi:10.3390/md10051044
Received: 1 March 2012; in revised form: 10 April 2012 / Accepted: 18 April 2012 / Published: 9 May 2012
Show/Hide Abstract | Cited by 1 | PDF Full-text (4668 KB) | HTML Full-text | XML Full-text

by , , , ,  and
Mar. Drugs 2013, 11(3), 584-598; doi:10.3390/md11030584
Received: 18 December 2012; in revised form: 12 January 2013 / Accepted: 15 February 2013 / Published: 26 February 2013
Show/Hide Abstract | Cited by 1 | PDF Full-text (735 KB) | HTML Full-text

Last update: 7 August 2014

Mar. Drugs EISSN 1660-3397 Published by MDPI AG, Basel, Switzerland RSS E-Mail Table of Contents Alert